By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

HanAll BioPharma Co., Ltd. 

6th Fl, I-Space Building, 11-10
Sincheon-Dong
Seoul    138-922  Korea
Phone: 82-2-2204-1753-9 Fax: 82-2-414-1951


SEARCH JOBS








Company News
HanAll BioPharma Co., Ltd. (009420.KS) Release: U.S. IND Accepted by the FDA in Support of the Clinical Development HL 007, a Unique Fixed Dose Combination to Treat Cardiovascular Disease 7/9/2010 5:09:00 PM
Han All Pharmaceutical Co., Ltd. (009420.KS) Receives U.S. PTO Notice Of Allowance For Vitatropin(TM), Modified Human Growth Hormone 4/2/2010 12:32:03 PM
Han All Pharmaceutical Co., Ltd. (009420.KS) Receives Issue Notification from the U.S. Patent and Trademark Office for its lead Hanferon(TM) (Protease resistant Interferon-alpha) Molecule 11/24/2009 1:17:32 PM
Han All Pharmaceutical Co., Ltd. (009420.KS) Awarded $3.2 MM USD from the South Korean Government to Support Global Development of its Novel Hanferon(TM) SC Protein Therapeutic 7/21/2009 2:05:01 PM
Han All Pharmaceutical Co., Ltd. (009420.KS) Acquires Global Rights To Nautilus Biotech's Protein Engineering Technology For Developing Novel Oral And Injectable Therapeutic Proteins 6/29/2009 1:49:11 PM
Han All Pharmaceutical Co., Ltd. (009420.KS) And Yuhan Corporation Complete License Agreement For A Unique Cardiovascular Combination Product For The Korean Market 6/4/2009 12:56:43 PM
Han All Pharmaceutical Co., Ltd. (009420.KS) to Present its Oral and Injectable Protein Therapeutic Program at 2009 Biotechnology Industry Organization (BIO) International Conference 5/14/2009 3:05:12 PM
Nautilus Biotech and Han All Pharmaceutical Co., Ltd. (009420.KS) Announce License Agreement to Develop Three Nautilus Biotech Products in South Korea 3/6/2007 1:15:53 PM
Atrix Laboratories, Inc. (ATRX) Licenses Prostate Cancer Products In Korea10/19/2005 5:09:49 PM
//-->